A 2025 systematic review of the musculoskeletal literature found that BPC-157 improved outcomes in muscle, tendon, ligament, and bone injury models, while noting that the evidence comes largely from animal studies [1]
AndersenALundAKnopFKVilsbllT
However, they may not always capture the full range of patient experiences
This peptide has been studied for its potential to stimulate lipolysis, reduce fat accumulation, and improve overall body composition
Growth Hormone Releasing Fragment
Thus, to highlight possible application of pentadecapeptide BPC 157 in both IBD and multiple sclerosis patients, this study shows BPC 157's potential to counteract the consequences of the cuprizone application, used in an extremely high regimen that highly exceeds those commonly applied (62)